Maccora D, Guerreri M, Malafronte R, DAlo F, Hohaus S, De Summa M
Diagnostics (Basel). 2025; 15(4).
PMID: 40002583
PMC: 11854662.
DOI: 10.3390/diagnostics15040432.
Triumbari E, Morland D, Gatta R, Boldrini L, De Summa M, Chiesa S
Ann Hematol. 2025; 104(1):641-651.
PMID: 39808225
PMC: 11868178.
DOI: 10.1007/s00277-025-06190-8.
Boldrini L, Chiloiro G, Di Franco S, Romano A, Smiljanic L, Tran E
Radiat Oncol. 2024; 19(1):94.
PMID: 39054479
PMC: 11271028.
DOI: 10.1186/s13014-024-02492-9.
Moro F, Vagni M, Tran H, Bernardini F, Mascilini F, Ciccarone F
Ultrasound Obstet Gynecol. 2024; 65(3):353-363.
PMID: 38748935
PMC: 11872347.
DOI: 10.1002/uog.27680.
Chiloiro G, Cusumano D, Romano A, Boldrini L, Nicoli G, Votta C
Cancers (Basel). 2023; 15(12).
PMID: 37370692
PMC: 10296157.
DOI: 10.3390/cancers15123082.
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
Lococo F, Boldrini L, Diepriye C, Evangelista J, Nero C, Flamini S
BMC Cancer. 2023; 23(1):540.
PMID: 37312079
PMC: 10262371.
DOI: 10.1186/s12885-023-10997-x.
Baseline F-FDG PET/CT Radiomics in Classical Hodgkin's Lymphoma: The Predictive Role of the Largest and the Hottest Lesions.
Triumbari E, Gatta R, Maiolo E, De Summa M, Boldrini L, Mayerhoefer M
Diagnostics (Basel). 2023; 13(8).
PMID: 37189492
PMC: 10137254.
DOI: 10.3390/diagnostics13081391.
QuantImage v2: a comprehensive and integrated physician-centered cloud platform for radiomics and machine learning research.
Abler D, Schaer R, Oreiller V, Verma H, Reichenbach J, Aidonopoulos O
Eur Radiol Exp. 2023; 7(1):16.
PMID: 36947346
PMC: 10033788.
DOI: 10.1186/s41747-023-00326-z.
MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation.
Chiesa S, Russo R, Beghella Bartoli F, Palumbo I, Sabatino G, Cannata M
Front Med (Lausanne). 2023; 10:1059712.
PMID: 36744131
PMC: 9892450.
DOI: 10.3389/fmed.2023.1059712.
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study.
Rossi E, Boldrini L, Maratta M, Gatta R, Votta C, Tortora G
Hum Vaccin Immunother. 2023; 19(1):2172926.
PMID: 36723981
PMC: 10012916.
DOI: 10.1080/21645515.2023.2172926.
Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [F]FDG PET/CT: A Comparison between Two PET/CT Scanners.
Dondi F, Gatta R, Albano D, Bellini P, Camoni L, Treglia G
J Clin Med. 2023; 12(1).
PMID: 36615053
PMC: 9820870.
DOI: 10.3390/jcm12010255.
Preoperative Tumor Texture Analysis on MRI for High-Risk Disease Prediction in Endometrial Cancer: A Hypothesis-Generating Study.
Micco M, Gui B, Russo L, Boldrini L, Lenkowicz J, Cicogna S
J Pers Med. 2022; 12(11).
PMID: 36579601
PMC: 9696574.
DOI: 10.3390/jpm12111854.
Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?.
De Bari B, Lefevre L, Henriques J, Gatta R, Falcoz A, Mathieu P
Cancers (Basel). 2022; 14(16).
PMID: 36011035
PMC: 9406583.
DOI: 10.3390/cancers14164043.
CT-Based Radiomics and Deep Learning for BRCA Mutation and Progression-Free Survival Prediction in Ovarian Cancer Using a Multicentric Dataset.
Avesani G, Tran H, Cammarata G, Botta F, Raimondi S, Russo L
Cancers (Basel). 2022; 14(11).
PMID: 35681720
PMC: 9179845.
DOI: 10.3390/cancers14112739.
CT-based radiomics modeling for skull dysmorphology severity and surgical outcome prediction in children with isolated sagittal synostosis: a hypothesis-generating study.
Calandrelli R, Boldrini L, Tran H, Quinci V, Massimi L, Pilato F
Radiol Med. 2022; 127(6):616-626.
PMID: 35538388
PMC: 9130191.
DOI: 10.1007/s11547-022-01493-6.
Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort.
Boldrini L, Lenkowicz J, Orlandini L, Yin G, Cusumano D, Chiloiro G
Radiat Oncol. 2022; 17(1):78.
PMID: 35428267
PMC: 9013126.
DOI: 10.1186/s13014-022-02048-9.
The impact of radiomics in diagnosis and staging of pancreatic cancer.
Casa C, Piras A, DAviero A, Preziosi F, Mariani S, Cusumano D
Ther Adv Gastrointest Endosc. 2022; 15:26317745221081596.
PMID: 35342883
PMC: 8943316.
DOI: 10.1177/26317745221081596.
A Predictive Model of 2yDFS During MR-Guided RT Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
Chiloiro G, Boldrini L, Preziosi F, Cusumano D, Yadav P, Romano A
Front Oncol. 2022; 12:831712.
PMID: 35280799
PMC: 8907443.
DOI: 10.3389/fonc.2022.831712.
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy.
Chiloiro G, Cusumano D, Boldrini L, Romano A, Placidi L, Nardini M
BMC Cancer. 2022; 22(1):67.
PMID: 35033008
PMC: 8760695.
DOI: 10.1186/s12885-021-09158-9.
Fractal-Based Radiomic Approach to Tailor the Chemotherapy Treatment in Rectal Cancer: A Generating Hypothesis Study.
Di Dio C, Chiloiro G, Cusumano D, Catucci F, Boldrini L, Romano A
Front Oncol. 2021; 11:774413.
PMID: 34956893
PMC: 8695680.
DOI: 10.3389/fonc.2021.774413.